Forbes July 30, 2024
Topline
Novo Nordisk’s weight loss and diabetes drug semaglutide—the drug in branded medications like Wegovy and Ozempic—may help people quit smoking, new research published Monday suggests, adding to evidence the wildly popular drugs could also help treat addiction as companies eye new markets amid growing reports GLP-1 drugs could be applied to a diverse array of conditions like heart disease, dementia and sleep apnea.
Key Facts
How Can Glp-1 Drugs Like Ozempic And Wegovy Help Treat Addiction?
There is no definitive evidence GLP-1 drugs like semaglutide can help treat addiction. But there have been increasing reports they have helped people curb addictive behavior for things like drinking, smoking tobacco, cannabis, other drugs like cocaine, skin picking, gambling and even shopping...
Today's Sponsors
Today's Sponsor